Livzon Pharmaceutical Group (HK:1513) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Livzon Pharmaceutical Group’s financial report for the third quarter of 2024 reveals a slight decline in operating income by 5.59% year-on-year, while net profit attributable to shareholders increased by 7.45%. The company’s basic earnings per share rose by 8%, indicating a steady performance amidst the challenging market conditions.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.